Plexus Corp. (NASDAQ:PLXS) Given Average Rating of “Moderate Buy” by Analysts

Plexus Corp. (NASDAQ:PLXSGet Free Report) has earned a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $194.20.

A number of equities analysts have issued reports on PLXS shares. Weiss Ratings upgraded Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, March 6th. Stifel Nicolaus boosted their target price on shares of Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a report on Friday, January 30th. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. Wall Street Zen lowered shares of Plexus from a “buy” rating to a “hold” rating in a research note on Sunday, March 8th. Finally, Needham & Company LLC lifted their price target on shares of Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research report on Friday, January 30th.

View Our Latest Research Report on Plexus

Insider Activity

In other news, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $203.06, for a total value of $873,767.18. Following the sale, the chief accounting officer directly owned 20,099 shares of the company’s stock, valued at $4,081,302.94. The trade was a 17.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman Dean A. Foate sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $204.89, for a total value of $1,024,450.00. Following the completion of the sale, the chairman owned 15,000 shares in the company, valued at $3,073,350. The trade was a 25.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 49,495 shares of company stock valued at $10,009,836. 1.78% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Plexus

Institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Plexus by 0.6% in the 3rd quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company’s stock worth $533,016,000 after purchasing an additional 22,374 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Plexus by 0.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,457 shares of the technology company’s stock valued at $201,903,000 after purchasing an additional 7,051 shares during the last quarter. American Century Companies Inc. increased its stake in Plexus by 44.2% during the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock valued at $159,722,000 after purchasing an additional 338,119 shares in the last quarter. State Street Corp increased its stake in Plexus by 2.3% during the 2nd quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock valued at $143,361,000 after purchasing an additional 24,115 shares in the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in Plexus by 4.0% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 915,296 shares of the technology company’s stock worth $132,434,000 after buying an additional 35,237 shares during the last quarter. 94.45% of the stock is currently owned by institutional investors.

Plexus Price Performance

PLXS opened at $207.35 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. Plexus has a 52-week low of $103.43 and a 52-week high of $220.17. The stock has a market capitalization of $5.55 billion, a PE ratio of 32.25 and a beta of 0.75. The stock’s 50 day moving average price is $198.09 and its 200-day moving average price is $167.01.

Plexus (NASDAQ:PLXSGet Free Report) last posted its earnings results on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, topping the consensus estimate of $1.77 by $0.01. The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the company posted $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, equities research analysts predict that Plexus will post 5.9 EPS for the current year.

About Plexus

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Stories

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.